These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21832236)

  • 41. [Immunogenetics and new therapies in type I diabetes mellitus].
    Gannage-Yared MH
    J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.
    Giannoukakis N; Pietropaolo M; Trucco M
    Diabetes Nutr Metab; 2002 Jun; 15(3):173-203. PubMed ID: 12173733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunological disorder in diabetes mellitus].
    Takeuchi K; Jodo S; Koike T
    Nihon Rinsho; 1997 Oct; 55 Suppl():700-4. PubMed ID: 9392184
    [No Abstract]   [Full Text] [Related]  

  • 45. National Diabetes Month: headlines from 2010.
    Strauch I
    Diabetes Self Manag; 2010; 27(6):23-4, 26. PubMed ID: 21291147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Reaction on 'Less need for insulin, a surprising effect of phototherapy in insulin-dependent diabetes mellitus'].
    Meesters Y
    Tijdschr Psychiatr; 2009; 51(12):975-7. PubMed ID: 20047170
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment and continuous control of infantile and juvenile diabetes].
    Orsini M; Campea L
    Clin Ter; 1971 Aug; 58(4):287-322. PubMed ID: 5158277
    [No Abstract]   [Full Text] [Related]  

  • 48. Can restoring immune balance be the ultimate therapy for type 1 diabetes?
    Uchigata Y
    J Diabetes Investig; 2016 Nov; 7(6):819-821. PubMed ID: 27181881
    [No Abstract]   [Full Text] [Related]  

  • 49. Innovative immunological strategies for type 1 diabetes.
    Vives-Pi M; Pujol-Autonell I
    Endocrinol Nutr; 2015 Nov; 62(9):419-21. PubMed ID: 26342847
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunotherapy of type 1 diabetes mellitus.
    Chatenoud L
    Curr Dir Autoimmun; 2001; 4():333-50. PubMed ID: 11569410
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunopathogenesis and immunotherapy of type I diabetes mellitus].
    Kuraeva TL
    Probl Endokrinol (Mosk); 1991; 37(1):63-7. PubMed ID: 2027876
    [No Abstract]   [Full Text] [Related]  

  • 52. Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
    Lord S; Greenbaum CJ
    Pharmacol Res; 2015 Aug; 98():3-8. PubMed ID: 25771310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?
    Ludvigsson J
    Expert Rev Vaccines; 2012 Mar; 11(3):263-5. PubMed ID: 22380817
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapy: Immunotherapy for T1DM--targeting innate immunity.
    Wong FS; Wen L
    Nat Rev Endocrinol; 2013 Jul; 9(7):384-5. PubMed ID: 23732280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type 1 diabetes immunological tolerance and immunotherapy.
    Chentoufi AA; Geenen V; Giannokakis N; Amrani A
    Clin Dev Immunol; 2011; 2011():103738. PubMed ID: 22190967
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune Intervention for Type 1 Diabetes.
    Nambam B; Bratina N; Schatz D
    Diabetes Technol Ther; 2018 Feb; 20(S1):S86-S93. PubMed ID: 29437480
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune intervention studies in insulin-dependent diabetes mellitus.
    Skyler JS
    Diabetes Metab Rev; 1987 Oct; 3(4):1017-35. PubMed ID: 3315520
    [No Abstract]   [Full Text] [Related]  

  • 58. Childhood diabetes. A contemporary re-evaluation.
    O'Brien D
    Clin Pediatr (Phila); 1966 Jan; 5(1):21-8. PubMed ID: 5900376
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy of type I diabetes: rationale, results and prospects.
    Pozza G; Pastore MR; Bosi E
    Pharmacol Res; 1992 Sep; 26 Suppl 2():110-1. PubMed ID: 1409267
    [No Abstract]   [Full Text] [Related]  

  • 60. Editorial - Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity.
    Infante M; Ricordi C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8702-8704. PubMed ID: 31646605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.